// App-Quantinova.ai

403 : Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin Lymphoma

Researchers

Presenter

  • Martin Hutchings

Principal Investigators

  • Carmelo Carlo-Stella

  • Emmanuel Bachy

  • Fritz Offner

  • Franck Morschhauser

  • Michael Crump

  • Gloria Iacoboni

  • Anna Sureda Balari

  • Joaquin Martinez-Lopez

  • Linda Lundberg

  • Mark Dixon

  • David Perez Callejo

  • James Relf

  • David Carlile

  • Emily Piccione

  • Kathryn Humphrey

  • Michael Dickinson

Medical Centers

  • Rigshospitalet, Copenhagen, Denmark

  • Humanitas Clinical and Research Center - IRCCS,Humanitas University,Milan,Italie

  • Hospices Civils de Lyon, Universite Claude Bernard, Pierre Benite, France

  • Universitair Ziekenhuis Gent, Ghent, Belgium

  • Hopital Claude Huriez, Centre Hospitalier Regional Universitaire de Lille, Lillie, France

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Institut Catala D'Oncologia. ICO Duran i Reinals, Hospitalet Del Llobregat, Spain

  • Hospital Universitario 12 de Octubre (H12O), Centro Nacional de Investigaciones Oncológicas (CNIO)-H12O and Universidad Complutense de Madrid,Madrid,Spain

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Genentech, Inc., South San Francisico, CA

  • Peter MacCallum Cancer Center, Royal Melbourne Hospital, and University of Melbourne ,Melbourne,Australia

Locations

  • Denmark

  • Italy

  • France

  • Belgium

  • Canada

  • Spain

  • Switzerland

  • United Kingdom

  • United States

  • Australia

Companies

  • F. Hoffmann-La Roche

  • Feng Chi Biotech Cor

  • Genentech, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non-Hodgkin's Lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Obinutuzumab

  • Obinutuzumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT03075696

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved